Research

TRP-PR Research & Study Results

Real outcome data from people who serve. All data was collected by Healing the Hero, a 501(c)(3) nonprofit, using the Trauma Resiliency Protocol-Performance Recovery (TRP-PR). Scores are group averages before and after TRP-PR.

Published research: A Pilot Study of a Trauma Resiliency Protocol for Law Enforcement Officers With Posttraumatic Stress Disorder Symptoms — Maguire et al., Arizona State University, Journal of Occupational and Environmental Medicine (2024), 128 law enforcement officers.
Key results

Results by study group

394

Study Group 1

67 women / 327 men · avg age 43.8 · avg 1.9 doses
PCL-5 · PTSD46 → 6.98
GAD-7 · Anxiety13.31 → 2.33
PHQ-9 · Depression14.28 → 2.37
490

Study Group 2

157 women / 333 men · avg age 46.0 · 1–5 doses of TRP-PR
PCL-5 · PTSD44.7 → 0.9
GAD-7 · Anxiety11.0 → 0.3
PHQ-9 · Depression13.6 → 0.3
  • 490 of 490 improved (100%); none got worse
  • All 379 who started in the PTSD range finished below it
  • PHQ-9 Q9 (thoughts of death or self-harm): 164 → 2
105

Civilians: Spouses & Minor Children

84 spouses · 21 minor children
Spouses · PCL-542.7 → 0.5
Minor children · PCL-540.1 → 0.0
89

ASU qEEG Study

105 participants (61 veterans) · 89 with paired pre/post scores
PCL-5 · PTSD46.9 → 0.8
GAD-7 · Anxiety12.8 → 0.4
PHQ-9 · Depression14.3 → 0.4
  • 89 of 89 improved. All fall below the PTSD threshold.
At a glance

Average scores, before → after

GroupParticipantsPCL-5 (of 80)GAD-7 (of 21)PHQ-9 (of 27)
Study Group 139446 → 6.9813.31 → 2.3314.28 → 2.37
Study Group 249044.7 → 0.911.0 → 0.313.6 → 0.3
Spouses8442.7 → 0.5——
Minor children2140.1 → 0.0——
ASU qEEG (paired)8946.9 → 0.812.8 → 0.414.3 → 0.4

Spouses are also counted within Study Group 2; groups should not be added together as a unique total.

Methodology

How results are measured

PCL-5 — PTSD symptoms, 0–80. Screening range 31–80.

GAD-7 — Anxiety, 0–21. Moderate 10–14 · Severe 15–21.

PHQ-9 — Depression, 0–27. Moderate 10–14 · Moderately severe 15–19 · Severe 20–27.

Lower scores mean fewer reported symptoms. These are self-report screening tools, not a diagnosis. Before-and-after observations do not by themselves establish causation.

Longevity

Long-term follow-up

Participants in the ASU qEEG study (57) were re-measured about 11 months after their post scores, on average. Their gains held.

MeasurePrePostFollow-up
PTSD (PCL-5)47.60.50.1
Depression (PHQ-9)14.60.40.0
Anxiety (GAD-7)13.20.20.0
Ongoing research

Current & planned studies

Arizona State University

Primary investigator: Dr. Maguire

PCL-5, GAD-7, PHQ-9 and ACEs questionnaires, a non-invasive qEEG brain scan, 1–5 doses of TRP-PR, then retesting and a second qEEG scan.

San Diego State University (planned)

Primary investigator: Dr. Tereza Trejbalova

A randomized controlled trial comparing human and AI delivery of TRP with corrections officers. IRB oversight planned through SDSU.

Next step

Bring TRP-PR to your team

For agencies, peer-support teams, pastoral counselors, licensed medical professionals and ministry teams.

Explore Training   Book a Call